CONTACT
About us
About NanoPhoria
Team
Investors
Therapeutic focus
Our Platform
Drug Delivery Platform
Pipeline
Background Science
Clinical Programs
NP-MP1
News
Press releases
Press releases
22 May 2022
NanoPhoria receives a 3.5M€ seed grant from Sofinnova Partners a leading European life sciences venture capital firm based in Paris, London and Milan
BACK